Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Ockham Research (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Not So FAST! Fastenal Drops on Solid Earnings

% of readers think this story is Fact. Add your two cents.


Fastenal (FAST) reported second quarter earnings of 47 cents per share on revenue of $571 million, which topped analysts’ forecasts of 44 cents on sales of $568.7 million.  In addition to topping Wall Street’s expectations, the company also easily exceeded last year’s second quarter results of 29 cents per share in earnings with revenue growth of 20% since that period.  The maker of nuts, bolts and other fastening devices and equipment saw net income rise 59%, but comparisons are still quite favorable as business fell off sharply during the recession. 

Demand from both manufacturing and non-residential customers improved in the quarter, which is a welcome sign after a long streak of declines.  Fastenal’s gains in non-residential construction, while modest (up .5%), showed the first increase in more than a year.  Prompted by the stronger than expected rebound in demand, the company said it plans to open 80 to 95 new stores during the second half of the year in hopes of being prepared to take advantage of continued improvements in the construction sector.  The company declined to update their guidance for the rest of the year, but at least earnings are trending the right way.  The company has now topped analysts’ expectations after missing them in each quarter of fiscal 2009.

With Fastenal showing positive momentum and topping expectations it might surprise some that the stock is actually trading 3% lower on heavy volume, especially considering the rest of the market is roaring higher.  At Ockham, we became concerned about Fastenal’s valuation in mid-April as the stock reached a new 52-week high at nearly $57.  It was at that time that we downgraded FAST to Overvalued and have maintained that stance ever since.  The stock is very near the high end of its historically normal ranges of both price-to-cash earnings and price-to-sales, which suggests the market has already priced in quite a bit of fundamental improvement.  For example, historically FAST has traded between 21x and 35x times cash earnings per share, and Fastenal closed yesterday trading for a multiple of 31x.  Similarly, with price-to-sales per share around 3.5x, it is near the historical high end of the range at 2.2x to 3.6x.

While Fastenal is clearly experiencing fundamental improvement and starting to see growth return, it is clear to us that some of that has already been priced in.  At Ockham, we are value-oriented and try to find stocks that are fundamentally strong and appear priced attractive compared to historical norms.  The stock has appreciated 63% over the last twelve months, and we think value investors should look elsewhere for ways to play a recovery in construction and manufacturing.

Read the original story at Ockham Research



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login